Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Condition:   Advanced Epithelial Ovarian Cancer Intervention:   Drug: Carboplatin/paclitaxel Sponsors:   Cairo University;   Misr International University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials